SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-24-068245
Filing Date
2024-08-13
Accepted
2024-08-13 16:05:51
Documents
94
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ea0211023-10q_immucell.htm   iXBRL 10-Q 1222476
2 CERTIFICATION ea021102301ex31_immucell.htm EX-31 9563
3 CERTIFICATION ea021102301ex32_immucell.htm EX-32 5018
9 GRAPHIC image_001.jpg GRAPHIC 73293
10 GRAPHIC image_002.jpg GRAPHIC 64849
  Complete submission text file 0001213900-24-068245.txt   7865196

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE iccc-20240630.xsd EX-101.SCH 65893
5 XBRL CALCULATION FILE iccc-20240630_cal.xml EX-101.CAL 38917
6 XBRL DEFINITION FILE iccc-20240630_def.xml EX-101.DEF 315626
7 XBRL LABEL FILE iccc-20240630_lab.xml EX-101.LAB 587801
8 XBRL PRESENTATION FILE iccc-20240630_pre.xml EX-101.PRE 321290
97 EXTRACTED XBRL INSTANCE DOCUMENT ea0211023-10q_immucell_htm.xml XML 1143971
Mailing Address 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address 56 EVERGREEN DR PORTLAND ME 04103 2078782770
IMMUCELL CORP /DE/ (Filer) CIK: 0000811641 (see all company filings)

IRS No.: 010382980 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-12934 | Film No.: 241201372
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)